Intratumoral and peritumoral radiomics of MRI predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma

We read with great interest the article by Lin et al .[1][1] The use of programmed death receptor-1 inhibitors alongside chemotherapy in neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma (HNSCC) enhances response rates, but predicting pathologic complete response (pCR)